Patients with mild ischemic stroke did not benefit from treatment with the clot busting agent alteplase at 90 days compared to aspirin (325 mg) alone according to the PRISMS Trial phase IIb.
JAMA. 2018 Jul 10;320(20):156-166
Showing posts with label alteplase vs aspirin. Show all posts
Showing posts with label alteplase vs aspirin. Show all posts
Monday, August 27, 2018
Subscribe to:
Posts (Atom)